| Literature DB >> 34204613 |
Emanuela Sozio1,2, Alessio Bertini3, Giacomo Bertolino4, Francesco Sbrana5, Andrea Ripoli6, Fabio Carfagna7, Alessandro Giacinta1,2, Bruno Viaggi8, Simone Meini9, Lorenzo Ghiadoni10,11, Carlo Tascini1,2.
Abstract
Background andEntities:
Keywords: afebrile patients; emergency department; qSOFA; sepsis; septic shock
Mesh:
Year: 2021 PMID: 34204613 PMCID: PMC8231120 DOI: 10.3390/medicina57060612
Source DB: PubMed Journal: Medicina (Kaunas) ISSN: 1010-660X Impact factor: 2.430
Comparison between septic patients (n 651) and controls (n 363).
| Over All ( | Controls ( | Sepsis ( |
| |
|---|---|---|---|---|
| Gender (male) | 537 (53.0%) | 180 (49.6%) | 357 (54.8%) | 0.123 |
| Age (years) | 77.7 ± 13.5 | 77.6 ± 13.4 | 77.8 ± 13.5 | 0.857 |
| Hospital admission | 926 (91.3%) | 311 (85.7%) | 615 (94.5%) | <0.001 |
| ICU admission | 68 (6.7%) | 19 (5.2%) | 49 (7.5%) | 0.205 |
| ED discharge | 65 (6.4%) | 50 (13.8%) | 15 (2.3%) | <0.001 |
| Death in ED | 23 (2.3%) | 2 (0.56%) | 21 (3.2%) | 0.012 |
| Death during hospitalization | 161 (15.9%) | 30 (9.7%) | 131 (20.1%) | 0.001 |
| Charlson Comorbidity Index | 2 (1.0–4.0) | 2 (1–4) | 2 (1–4) | 0.239 |
| Cardiovascular disease | 550 (54.2%) | 208 (57.3%) | 342 (52.5%) | 0.163 |
| Renal insufficiency | 23 (2.3%) | 9 (2.5%) | 14 (2.2%) | 0.907 |
| Diabetes | 250 (24.7%) | 105 (28.9%) | 145 (22.3%) | 0.023 |
| COPD | 176 (17.4%) | 104 (28.7%) | 72 (11.1%) | <0.001 |
| Prosthetic device | 157 (15.5%) | 73 (20.1%) | 84 (12.9%) | 0.003 |
| Chronic hepatopathy | 46 (4.5%) | 18 (5.0%) | 28 (4.3%) | 0.745 |
| Immunosuppression | 88 (8.7%) | 33 (9.1%) | 55 (8.5%) | 0.817 |
| Cancer | 145 (14.3%) | 66 (18.2%) | 79 (12.1%) | 0.011 |
| Steroid therapy (in 30 days) | 154 (15.2%) | 77 (21.2%) | 77 (11.8%) | <0.001 |
| Trauma (in 30 days) | 51 (5.0%) | 11 (3.0%) | 40 (6.1%) | 0.043 |
| Surgery (in 30 days) | 37 (3.7%) | 3 (0.8%) | 34 (5.2%) | 0.001 |
| Presence of CVC | 62 (6.1%) | 7 (1.9%) | 55 (8.5%) | <0.001 |
| Presence of urinary catheter | 112 (11.1%) | 12 (3.3%) | 100 (15.7%) | <0.001 |
| Body temperature (°C) | 37.6 ± 1.2 | 36.9 ± 1.0 | 37.8 ± 1.2 | <0.001 |
| MAP | 119.2 ± 41.8 | 152.8 ± 33.8 | 101.0 ± 33.7 | <0.001 |
| GCS | 13.7 ± 3.0 | 14.2 ± 2.5 | 13.3 ± 3.2 | <0.001 |
| Septic shock | 96 (9.5%) | 0 (0.0%) | 96 (14.8%) | <0.001 |
| Shock index | 0.8 ± 0.3 | 0.7 ± 0.2 | 0.9 ± 0.3 | <0.001 |
| Positive qSOFA | 277 (27.3%) | 24 (8.1%) | 253 (38.9%) | <0.001 |
| SOFA score | 3 (2.0–5.0) | 2 (2–4) | 4 (3–6) | <0.001 |
| Lactate (mmol/L) | 1.6 (1.0–2.9) | 1.2 (0.8–1.9) | 2.1 (1.2–3.8) | <0.001 |
| WBC (/mmc) | 11.9 (8.4–16.9) | 10.0 (7.3–13.3) | 13.4 (9.3–19.6) | <0.001 |
| PCT (ng/mL) | 1.4 (0.3–7.8) | 0.1 (0.1–0.2) | 2.9 (0.9–13.1) | <0.001 |
| Creatinine (mg/dl) | 1.2 (0.8–1.8) | 1.0 (0.8–1.4) | 1.3 (0.9–2.1) | <0.001 |
| Bilirubin (mg/dl) | 0.8 (0.5–1.2) | 0.5 (0.3–0.9) | 0.9 (0.6–1.3) | <0.001 |
| Platelet count (/mmc) | 213 (153–293) | 226.5 (178–291) | 200 (142–293) | <0.001 |
Figure 1Model selected by BMA for in-hospital mortality in septic cases.
Bayesian mean of multivariate logistic regression performed to investigate the association with the in-hospital mortality outcome in septic cases.
| Variable | OR | 95% CI OR | |
|---|---|---|---|
| Male | 0.902 | 0.874–0.931 | 17 |
| Age | 1.000 | 0.999–1.001 | 1.8 |
| Charlson Comorbidity Index | 1.008 | 1.004–1.013 | 6.9 |
| CVC | 1.009 | 0.997–1.021 | 2.3 |
| SOFA score | 1.001 | 0.999–1.002 | 2.2 |
| GCS | 0.936 | 0.928–0.944 | 51.6 |
| PAM | 1.000 | 0.999–1.000 | 2.8 |
| Body Temperature | 0.687 | 0.673–0.701 | 92.5 |
| Lactate | 1.107 | 1.095–1.120 | 63.7 |
| White blood cells | 1.001 | 1.000–1.002 | 5.7 |
| Creatinine | 1.004 | 1.001–1.007 | 4.1 |
| Total bilirubin | 1.011 | 1.004–1.017 | 6.4 |
| Positive qSOFA | 2.144 | 2.002–2.297 | 71.7 |
| Shock index | 0.995 | 0.985–1.005 | 2 |
| Septic Shock | 6.582 | 6.289–6.88 | 100 |
Legend: the variables in italics are those that possess independent effect on mortality. Septic shock and positive qSOFA are risk factors for in-hospital mortality, while higher temperature is a protective factor.